Head-to-head trials showed patients lost more weight on tirzepatide than on semaglutide and by early 2025, prescription trends confirmed Novo was losing ground
Additionally, GLP-1 receptors in your brain's appetite centers trigger satiety signals that make you feel satisfied with smaller meals
Tizaro is a weight loss treatment that can support 15% to 22% body weight loss by targeting two key hunger hormones in the body to reduce appetite and control cravings
Saxenda is FDA-approved for the treatment of obesity, while Victoza is approved for the treatment of type 2 diabetes in patients ages ten and older
Skin type, age, and overall health can all factor into results
Unexpected circumstances may necessitate adjustments to your medication schedule, and we recognize the importance of flexibility in your tirzepatide treatment plan